Ginkgo Bioworks Holdings (DNA) Consolidated Net Income (2020 - 2025)
Historic Consolidated Net Income for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to -$80.8 million.
- Ginkgo Bioworks Holdings' Consolidated Net Income fell 4317.5% to -$80.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$339.5 million, marking a year-over-year increase of 4785.75%. This contributed to the annual value of -$547.0 million for FY2024, which is 3873.36% up from last year.
- Per Ginkgo Bioworks Holdings' latest filing, its Consolidated Net Income stood at -$80.8 million for Q3 2025, which was down 4317.5% from -$60.3 million recorded in Q2 2025.
- Ginkgo Bioworks Holdings' 5-year Consolidated Net Income high stood at -$54.5 million for Q2 2021, and its period low was -$1.6 billion during Q4 2021.
- Over the past 5 years, Ginkgo Bioworks Holdings' median Consolidated Net Income value was -$173.1 million (recorded in 2022), while the average stood at -$295.5 million.
- As far as peak fluctuations go, Ginkgo Bioworks Holdings' Consolidated Net Income crashed by 335911.55% in 2021, and later skyrocketed by 8921.63% in 2022.
- Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Consolidated Net Income stood at -$1.6 billion in 2021, then skyrocketed by 89.22% to -$173.1 million in 2022, then fell by 22.31% to -$211.7 million in 2023, then soared by 49.2% to -$107.5 million in 2024, then increased by 24.9% to -$80.8 million in 2025.
- Its Consolidated Net Income was -$80.8 million in Q3 2025, compared to -$60.3 million in Q2 2025 and -$91.0 million in Q1 2025.